Table 1.
Demographic and preoperative characteristics of the patients studied as furosemide and placebo groups
| Variable | Furosemide group (n=41) |
Placebo group (n=40) |
Total (N=81) |
P-value |
|---|---|---|---|---|
| Gender (M/F) | 23/18 | 24/16 | 47/34 | 0.823 |
| Age (years) | 52.95 ± 11.85 | 56.75±12.14 | 54.83±12.07 | 0.158 |
| Weight (kg) | 72.63±12.63 | 74.32±13.40 | 73.47±12.97 | 0.561 |
| Height (cm) | 162.98±11.20 | 162.65±9.63 | 162.82±10.40 | 0.885 |
| BMI (kg/m2) | 27.38±4.54 | 28.10±4.72 | 27.74±4.62 | 0.486 |
| Left ventricular ejection fraction | 0.50±0.07 | 0.49±0.06 | 0.49±0.06 | 0.554 |
| CABG | 27 (65/9%) | 27 (67.5%) | 54 (66.6%) | 0.368 |
| VHS | 13 (31.7%) | 11 (27.5%) | 24 (29.6%) | |
| Cardiac mass | 1 (2.4%) | 0 | 1 (1.2%) | |
| PTE | 0 | 2 (5%) | 2 (2.5%) | |
| Preoperative serum creatinine (mg/dL) | 1.15±0.23 | 1.11±0.21 | 1.13±0.22 | 0.380 |
| Preoperative BUN (mg/dL) | 18.93±5.6 | 19.98±6.1 | 19.44±5.85 | 0.424 |
| Preoperative eGFR (mL/min/1.73 m2) | 71.65±17.58 | 73.88±22.59 | 72.75±20.11 | 0.622 |
Note: The values are presented as frequency (%) or mean ± standard deviation.
Abbreviations: M, male; F, female, BMI, body mass index; CABG, coronary artery bypass graft surgery; VHS, valvular heart surgery; PTE, pulmonary thromboembolectomy; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate.